✦ LIBER ✦

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment

✍ Scribed by Lieven Baert; Gerben van ‘t Klooster; Willy Dries; Marc François; Alfons Wouters; Esther Basstanie; Koen Iterbeke; Fred Stappers; Paul Stevens; Laurent Schueller; Pieter Van Remoortere; Guenter Kraus; Piet Wigerinck; Jan Rosier

Book ID: 116438177
Publisher: Elsevier Science
Year: 2009
Tongue: French
Weight: 263 KB
Volume: 72
Category: Article
ISSN: 0939-6411
DOI: 10.1016/j.ejpb.2009.03.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and Disposition of Rilp

Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation

✍ van 't Klooster, G.; Hoeben, E.; Borghys, H.; Looszova, A.; Bouche, M. P.; van V 📂 Article 📅 2010 🏛 American Society for Microbiology 🌐 English ⚖ 945 KB

A prospective comparative study of rispe

A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis

✍ Kimura, Hiroshi; Kanahara, Nobuhisa; Komatsu, Naoya; Ishige, Minoru; Muneoka, Ka 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 498 KB

TREATMENT COMPLETION RATES OF OLANZAPINE

TREATMENT COMPLETION RATES OF OLANZAPINE AND RISPERIDONE IN LONG ACTING INJECTABLE FORMULATIONS FOR THE TREATMENT OF SCHIZOPHRENIA: A COMPARISON OF SINGLE ARM OPEN-LABEL STUDIES

✍ Haya Ascher-Svanum; William Montgmery; Allen Brnabic; Anthony Lawson; Oladapo To 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

2742 – A prospective comparative study o

2742 – A prospective comparative study of risperidone long-acting injection for treatment-resistant schizophrenia with dopamine supersensitivity psychosis

✍ Kimura, H.; Kanahara, N.; Komatsu, N.; Ishige, M.; Muneoka, K.; Yoshimura, M.; Y 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 33 KB